Analyst Consensus ?
ConsensusBuy35 ratings
Bullish2262.9%
Neutral1131.4%
Bearish25.7%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
Corteva, Inc. analyst ratings
Corteva, Inc. (CTVA) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$83.9Current
$53Low
$78.16Average
$103High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 12, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Aug 18, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 3, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Aug 3, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 23, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 21, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 20, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 14, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 11, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | May 28, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 21, 2026 |
| Argus Research | Buy | Buy | Maintain | Mar 31, 2026 |
| Keybanc | Overweight | Downgrade | Oct 3, 2025 | |
| Jefferies | Buy | Buy | Maintain | Jun 6, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Jun 12, 2024 |
| OTR Global | Negative | Mixed | Downgrade | Jun 7, 2024 |
| Canaccord Genuity | Buy | Buy | Maintain | May 3, 2024 |
| Loop Capital | Buy | Hold | Upgrade | Feb 12, 2024 |
| Exane BNP Paribas | Neutral | Underperform | Upgrade | Feb 2, 2024 |
| Roth MKM | Buy | Buy | Maintain | Jan 29, 2024 |
| Berenberg | Hold | Buy | Downgrade | Nov 27, 2023 |
| Fermium Research | Outperform | Outperform | Maintain | Oct 30, 2023 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 24, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 4, 2023 |
| Redburn Partners | Neutral | Buy | Downgrade | Jul 25, 2023 |
| Vertical Research | Buy | Hold | Upgrade | May 22, 2023 |
| Roth Capital | Buy | Buy | Maintain | Oct 8, 2021 |
| Monness, Crespi, Hardt | Neutral | Sell | Upgrade | Aug 9, 2021 |
| Redburn | Neutral | Buy | Downgrade | Jan 21, 2021 |
| Susquehanna | Positive | Neutral | Upgrade | Mar 31, 2020 |
| Edward Jones | Buy | Hold | Upgrade | Mar 19, 2020 |
| Bernstein | Outperform | Market Perform | Upgrade | Jan 23, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Oct 11, 2019 |
| Citi | Buy | Neutral | Upgrade | Aug 19, 2019 |
| Monness Crespi Hardt | Sell | Sell | Maintain | Jul 17, 2019 |
| Nomura | Neutral | Neutral | Maintain | Jun 10, 2019 |
Named analyst price targets
Upside is calculated against the persisted current price $83.9. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | David Begleiter | $101 | $77.75 | +20.4% | Aug 3, 2026 |
| BMO Capital | Joel Jackson | $100 | $78.71 | +19.2% | Aug 3, 2026 |
| RBC Capital | Arun Viswanathan | $103 | $86.78 | +22.8% | Jul 21, 2026 |
| Mizuho Securities | Analyst unavailable | $97 | $85.72 | +15.6% | Jul 14, 2026 |
| Mizuho Securities | Analyst unavailable | $96 | $85.25 | +14.4% | Jul 2, 2026 |
| Barclays | Benjamin Theurer | $91 | $74.46 | +8.5% | Jun 11, 2026 |
| UBS | Joshua Spector | $86 | $75.86 | +2.5% | Jun 9, 2026 |
| Morgan Stanley | Vincent Andrews | $95 | $79.89 | +13.2% | May 28, 2026 |
| RBC Capital | Arun Viswanathan | $95 | $78.62 | +13.2% | Apr 24, 2026 |
| Wells Fargo | Analyst unavailable | $90 | $80.29 | +7.3% | Apr 21, 2026 |
| UBS | Analyst unavailable | $88 | $83.56 | +4.9% | Apr 9, 2026 |
| Mizuho Securities | Analyst unavailable | $82 | $75.03 | -2.3% | Feb 17, 2026 |
| UBS | Joshua Spector | $80 | $72.6 | -4.6% | Feb 9, 2026 |
| RBC Capital | Analyst unavailable | $89 | $72.99 | +6.1% | Feb 5, 2026 |
| Oppenheimer | Analyst unavailable | $86 | $72.99 | +2.5% | Feb 5, 2026 |
| Goldman Sachs | Analyst unavailable | $88 | $75.12 | +4.9% | Feb 5, 2026 |
| Wells Fargo | Analyst unavailable | $85 | $75.12 | +1.3% | Feb 5, 2026 |
| Oppenheimer | Analyst unavailable | $78 | $72.63 | -7.0% | Jan 27, 2026 |
| Mizuho Securities | Edlain Rodriguez | $80 | $70.5 | -4.6% | Jan 16, 2026 |
| Oppenheimer | Analyst unavailable | $76 | $63.38 | -9.4% | Nov 7, 2025 |
| UBS | Analyst unavailable | $81 | $61.53 | -3.5% | Oct 30, 2025 |
| Oppenheimer | Analyst unavailable | $75 | $62.79 | -10.6% | Oct 22, 2025 |
| Wells Fargo | Analyst unavailable | $80 | $61.91 | -4.6% | Oct 16, 2025 |
| Mizuho Securities | Analyst unavailable | $78 | $65.61 | -7.0% | Oct 8, 2025 |
| UBS | Analyst unavailable | $85 | $64.56 | +1.3% | Oct 6, 2025 |
| Morgan Stanley | Analyst unavailable | $84 | $74.29 | +0.1% | Sep 15, 2025 |
| BMO Capital | Analyst unavailable | $86 | $74.29 | +2.5% | Sep 15, 2025 |
| Oppenheimer | Kristen Owen | $87 | $72.09 | +3.7% | Jul 15, 2025 |
| KeyBanc | Aleksey Yefremov | $71 | $60.29 | -15.4% | Apr 14, 2025 |
| KeyBanc | Aleksey Yefremov | $69 | $60.76 | -17.8% | Nov 21, 2024 |
| Citigroup | Patrick Cunningham | $68 | $59.12 | -19.0% | Oct 23, 2024 |
| Bank of America Securities | Steve Byrne | $67 | $57.3 | -20.1% | Oct 16, 2024 |
| Mizuho Securities | John Roberts | $61 | $57.85 | -27.3% | Sep 25, 2024 |
| Oppenheimer | Kriten Owen | $69 | $57.04 | -17.8% | Sep 17, 2024 |
| KeyBanc | Aleksey Yefremov | $62 | $53 | -26.1% | Aug 2, 2024 |
| Mizuho Securities | John Roberts | $60 | $51.89 | -28.5% | Jun 18, 2024 |
| Wolfe Research | Chris Parkinson | $68 | $51.9 | -19.0% | Jun 11, 2024 |
| Deutsche Bank | David Begleiter | $65 | $57.03 | -22.5% | May 6, 2024 |
| RBC Capital | Arun Viswanathan | $64 | $57.16 | -23.7% | May 6, 2024 |
| Canaccord Genuity | Bobby Burleson | $65 | $56.98 | -22.5% | May 3, 2024 |
| BMO Capital | Joel Jackson | $67 | $56.98 | -20.1% | May 3, 2024 |
| Jefferies | Laurence Alexander | $67 | $57 | -20.1% | Mar 28, 2024 |
| Loop Capital Markets | Christopher Kapsch | $65 | $55.04 | -22.5% | Feb 12, 2024 |
| BNP Paribas | Laurent Favre | $53 | $53.04 | -36.8% | Feb 2, 2024 |
| Wells Fargo | Analyst unavailable | $77 | $61.54 | -8.2% | Feb 3, 2023 |
| Citigroup | Analyst unavailable | $74 | $61.68 | -11.8% | Feb 3, 2023 |
| Morgan Stanley | Analyst unavailable | $80 | $62.12 | -4.6% | Jan 11, 2023 |
| Barclays | Analyst unavailable | $75 | $65.35 | -10.6% | Nov 17, 2022 |
| UBS | Analyst unavailable | $73 | $66.72 | -13.0% | Nov 16, 2022 |
| Credit Suisse | John Roberts | $68 | $51.26 | -19.0% | Jul 14, 2022 |
| Barclays | Benjamin Theurer | $71 | $53.22 | -15.4% | Jun 20, 2022 |
| Deutsche Bank | David Begleiter | $72 | $62.04 | -14.2% | Jun 6, 2022 |
| Argus Research | Bill Selesky | $69 | $60.91 | -17.8% | May 24, 2022 |
| Mizuho Securities | Analyst unavailable | $67 | $57.99 | -20.1% | Apr 29, 2022 |
| Roth Capital | Brian White | $56 | $50.25 | -33.3% | Feb 4, 2022 |
| Barclays | Duffy Fischer | $54 | $47.33 | -35.6% | Nov 5, 2021 |
| Deutsche Bank | David Begleiter | $55 | $44.79 | -34.4% | Aug 8, 2021 |
| Argus Research | Bill Selesky | $54 | $45.82 | -35.6% | May 17, 2021 |
| Bank of America Securities | Steve Byrne | $42 | $46.45 | -49.9% | May 10, 2021 |
Track every rating change on CTVA the moment it posts. Free to start.
Start free